Synthetic biology for synthetic chemistry

被引:295
作者
Keasling, Jay D. [1 ,2 ,3 ]
机构
[1] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA
关键词
D O I
10.1021/cb7002434
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The richness and versatility of biological systems make them ideally suited to solve some of the world's most significant challenges, such as converting cheap, renewable resources into energy-rich molecules; producing high-quality, inexpensive drugs to fight disease; and remediating polluted sites. Over the years, significant strides have been made in engineering microorganisms to produce fuels, bulk chemicals, and valuable drugs from inexpensive starting materials; to detect and degrade nerve agents as well as less toxic organic pollutants; and to accumulate metals and reduce radionuclides. The components needed to engineer the chemistry inside a microbial cell are significantly different from those commonly used to overproduce pharmaceutical proteins. Synthetic biology has had and will continue to have a significant impact on the development of these components to engineer cellular metabolism and microbial chassis to host the chemistry. The ready availability of more well-characterized gene expression components and hosts for chemical synthesis, standards for the connection of these components to make larger functioning devices, computer-aided design software, and debugging tools for biological designs will decrease both the time and the support needed to construct these designs. Some of the most important tools for engineering bacterial metabolism and their use for production of the antimalarial drug artemisinin are reviewed.
引用
收藏
页码:64 / 76
页数:13
相关论文
共 129 条
[51]   Modulation of gene expression from the arabinose-inducible araBAD promoter [J].
Khlebnikov, A ;
Skaug, T ;
Keasling, JD .
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2002, 29 (01) :34-37
[52]   Effect of lacY expression on homogeneity of induction from the Ptac and Ptrc promoters by natural and synthetic inducers [J].
Khlebnikov, A ;
Keasling, JD .
BIOTECHNOLOGY PROGRESS, 2002, 18 (03) :672-674
[53]   Homogeneous expression of the PBAD promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter [J].
Khlebnikov, A ;
Datsenko, KA ;
Skaug, T ;
Wanner, BL ;
Keasling, JD .
MICROBIOLOGY-SGM, 2001, 147 :3241-3247
[54]   Regulatable arabinose-inducible gene expression system with consistent control in all cells of a culture [J].
Khlebnikov, A ;
Risa, O ;
Skaug, T ;
Carrier, TA ;
Keasling, JD .
JOURNAL OF BACTERIOLOGY, 2000, 182 (24) :7029-7034
[55]   Timeline - Metabolic engineering for drug discovery and development [J].
Khosla, C ;
Keasling, JD .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (12) :1019-1025
[56]   Enzymes for chemical synthesis [J].
Koeller, KM ;
Wong, CH .
NATURE, 2001, 409 (6817) :232-240
[57]   Engineering a reduced Escherichia coli genome [J].
Kolisnychenko, V ;
Plunkett, G ;
Herring, CD ;
Fehér, T ;
Pósfai, J ;
Blattner, FR ;
Pósfai, G .
GENOME RESEARCH, 2002, 12 (04) :640-647
[58]   Internal ribosome entry sites in cellular mRNAs: Mystery of their existence [J].
Komar, AA ;
Hatzoglou, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) :23425-23428
[59]   Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy [J].
Korenromp, EL ;
Williams, BG ;
Gouws, E ;
Dye, C ;
Snow, RW .
LANCET INFECTIOUS DISEASES, 2003, 3 (06) :349-358
[60]  
Kuo H, 1996, BIOTECHNOL BIOENG, V52, P633, DOI 10.1002/(SICI)1097-0290(19961220)52:6<633::AID-BIT1>3.0.CO